Calendar Neuren Pharmaceuticals Limited

Equities

Delayed Australian S.E. Other stock markets 07:19:55 15/05/2024 am IST			5-day change	1st Jan Change
21.6 ^AUD	+6.93%		+7.31%	-13.62%

09/05	Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million	MT
24/04	Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments	MT

3bcc93f79e34.q7xy1O3F39-Ob0I-2c7L-VNHHka4snkiMtaKvxGOWBw.m_I5g4Cjmu_0Cw8M77iYijUxdzbV9k0PZ7X88FvsaGXJjhOSiKurs-EFKQ~c49e69e620e0e3d8733d42e87f26dddd

28/05/2024 10:00 am	Annual General Meeting
27/08/2024	Q2 2024 Earnings Release (Projected)
04/03/2025	Q4 2024 Earnings Release (Projected)
26/08/2025	Q2 2025 Earnings Release (Projected)
03/03/2026	Q4 2025 Earnings Release (Projected)

24/04/2024 05:35 am	March 2024 Sales and Revenue Release - Activities Report
29/02/2024 11:00 am	Q4 2023 Earnings Call
29/02/2024 10:10 am	Q4 2023 Earnings Release
31/01/2024 07:39 am	December 2023 Sales and Revenue Release - Activities Report
18/12/2023 05:00 am	NNZ-2591 Phase II Clinical Trial Results Call
20/10/2023 04:00 am	September 2023 Sales and Revenue Release - Activities Report
28/08/2023 06:30 am	Q2 2023 Earnings Call
28/08/2023 04:58 am	Q2 2023 Earnings Release
31/07/2023 05:01 am	June 2023 Sales and Revenue Release - Activities Report
14/07/2023 05:00 am	Business Update Call
08/06/2023 11:30 pm	Jefferies Global Healthcare Conference
28/04/2023 04:54 am	March 2023 Sales and Revenue Release - Activities Report
14/03/2023 03:30 am	DAYBUE Approval Call
24/02/2023 04:06 am	FY 2022 Earnings Release
31/01/2023 04:19 am	December 2022 Sales and Revenue Release - Activities Report
17/11/2022	Jefferies London Healthcare Conference
27/10/2022 04:05 am	September 2022 Sales and Revenue Release - Activities Report
14/09/2022	ASX Small & Mid-Cap Conference
24/08/2022 04:49 am	Interim 2022 Earnings Release
29/07/2022	June 2022 Sales and Revenue Release - Activities Report

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million AUD	Released Forecast Spread	1,02 0,40 154%	0,96 1,00 -3.6%	3,64 1,25 190.88%	17,0 15,7 8.55%	232 231 0.23%	152
EBITDA Million AUD	Released Forecast Spread	-11,1 -14,0 20.91%	-8,56 -11,7 26.87%	-7,79 -9,70 19.72%	-1,59 -6,74 76.48%	199 197 1.35%	118
EBIT Million AUD	Released Forecast Spread	-10,6 -14,0 24.61%	-8,56 -11,7 26.82%	-7,79 -9,70 19.64%	-1,60 -6,46 75.3%	199 196 1.46%	122
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	-10,8 -13,7 21.05%	-9,19 -11,1 17.18%	-7,79 -9,40 17.08%	0,18 -6,57 102.8%	205 202 1.57%	146
Net income Million AUD	Released Forecast Spread	-10,8 -13,7 21.05%	-9,19 -11,1 17.18%	-7,79 -9,24 15.69%	0,18 -6,01 103.06%	157 171 -8%	91,3
EPS AUD	Released Forecast Spread	-0,11 -0,14 21.17%	-0,09 -0,10 16.5%	-0,07 -0,08 15.38%	0,00 -0,05 102.13%	1,20 1,35 -11.22%	0,72
Announcement Date		25/02/20	23/02/21	23/02/22	23/02/23	29/02/24	-

Fiscal Period	December	2019 S2	2020 S1	2020 S2	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2
Net sales Million AUD	Released Forecast Spread	0,73 0,40 83.25%	0,55 0,00 -	0,41 1,00 -59%		3,40 2,50 36.08%	0,28 0,00 -	16,8 13,9 20.5%	64,4 63,1 2.07%	169 170 -0.35%	24,9	165
EBITDA Million AUD	Released Forecast Spread	-3,17 -6,00 47.2%	-4,76 -5,90 19.36%	-3,80 -6,40 40.66%					49,6 46,0 7.89%	151 179 -15.75%	7,60	145
EBIT Million AUD	Released Forecast Spread	-2,93 -6,10 51.95%	-4,76 -5,90 19.31%	-3,80 -6,40 40.61%			-5,90 0,00 -	4,31 -3,40 226.71%	49,6 49,3 0.65%	151 204 -25.79%
Earnings before Tax (EBT) Million AUD	Released Forecast Spread	-2,93 -5,80 49.47%	-4,76 -5,80 17.91%	-4,43 -6,30 29.65%					49,6 46,5 6.71%	156 204 -23.77%
Net income Million AUD	Released Forecast Spread	-2,93 -5,80 49.47%	-4,76 -5,80 17.91%	-4,43 -6,30 29.65%	-7,96	0,17 -2,50 106.8%	-7,05 -4,50 -56.76%	7,24 -3,40 312.88%	47,8 49,6 -3.52%	109 138 -20.61%
EPS AUD	Released Forecast Spread								0,37 0,36 2.22%	0,83 1,15 -27.25%	0,47	0,61
Announcement Date		25/02/20	25/08/20	23/02/21	24/08/21	23/02/22	23/08/22	23/02/23	27/08/23	29/02/24	-	-

17/05/2024	J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
17/05/2024	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
21/05/2024	TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release (Projected)
22/05/2024	CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release (Projected)
22/05/2024	GLAND PHARMA LIMITED: Q4 2024 Earnings Release
23/05/2024	ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release (Projected)
24/05/2024	TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
27/05/2024	NATCO PHARMA LIMITED: Q4 2024 Earnings Release
27/05/2024	DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)
28/05/2024	IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release (Projected)

Today	MANKIND PHARMA LIMITED: Q4 2024 Earnings Release
Today	CRESCO LABS INC.: Q1 2024 Earnings Release
Today	GRANULES INDIA LIMITED: Q4 2024 Earnings Release
Today	EISAI CO., LTD.: Q4 2023 Earnings Release
Today	DERMAPHARM HOLDING SE: Q1 2024 Earnings Release
14/05/2024 11:00 am	BAYER AG: Q1 2024 Earnings Release
14/05/2024	BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release
14/05/2024	SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION: Q1 2024 Earnings Release (Projected)
14/05/2024	LIQUIDIA CORPORATION: Q1 2024 Earnings Release
14/05/2024	PRESTIGE CONSUMER HEALTHCARE INC.: Q4 2024 Earnings Release